After a four-year effort led by the Sjögren’s Foundation, new health statistics codes in the U.S. — known as ICD-10 codes — recognizing Sjögren’s syndrome as a distinctive condition from “sicca” are now in effect. The codes are officially known as the International Statistical Classification of Diseases and…
News
Tennis champion and activist Venus Williams will be featured in “Hear Me,” an advertising campaign by Blue Shield of California seeking to increase attention to and end the bias and inequalities currently seen in access to healthcare in the U.S. “I am deeply passionate about prioritizing health and well-being,…
The Sjögren’s Foundation, a nonprofit health organization focused on increasing research, education, and awareness about Sjögren’s syndrome, has announced its most dedicated volunteers who were honored recently at the foundation’s 2021 Virtual National Patient Conference. “Every year, the Foundation recognizes our most dedicated volunteers through awards that are…
A new study is seeking adults with autoimmune diseases, including those with Sjogren’s syndrome, who have received a COVID-19 vaccine or are planning to do so. Conducted by the University of Pittsburgh Medical Center (UPMC), the CoVER study is investigating if patients with autoimmune diseases respond similarly…
The Sjögren’s Foundation has awarded a total of $200,000 to four U.S. research projects focused on identifying diagnostic biomarkers and improving treatment of Sjögren’s syndrome. The foundation’s Research Grants Program “places a high priority on both clinical and basic scientific research into the cause, prevention, detection, treatment, and cure…
A rare case of pancreatic cancer was reported in a 59-year-old woman two years after she was diagnosed with primary Sjögren’s syndrome. While primary Sjögren’s has been extensively linked to a higher risk of blood cancers, fewer studies have described a potential link with solid cancers. This case supports the importance of…
A salivary gland biopsy on the lower lip may be considered a safe procedure for diagnosing Sjögren’s syndrome, with relatively few and mild complications, a study found. According to its authors, proper management and follow-up may reduce the risk of complications from the biopsy and help in the recovery…
To combat the continued spread of COVID-19 and its Delta variant, Sjögren’s syndrome patients should get a third dose of the Pfizer or Moderna vaccine, the Sjögren’s Foundation has recommended, pursuant to Centers for Disease Control and Prevention (CDC) guidelines. The CDC — the United States’ public…
The Sjögren’s Foundation is calling on runners and walkers to take part in its Team Sjögren’s Training Program for a virtual event that will take place Nov. 25–28. The event will help increase awareness about the autoimmune condition and raise funds for research and education, the foundation announced in…
The findings of a new study support the development of Incyte‘s parsaclisib as a potential therapy for Sjögren’s syndrome and other autoimmune diseases. Parsaclisib, an oral inhibitor of phosphatidylinositol 3-kinase (PI3K) delta, was found to ease the symptoms of Sjögren’s and other disorders in a study using mouse models.
Recent Posts
- New study uses artificial intelligence to uncover Sjögren’s disease subtypes
- Blood molecule may offer new way to detect and track Sjögren’s disease
- A closer look at Sjögren’s disease: How Johnson & Johnson is driving patient-informed research
- Childhood-onset Sjögren’s can cause lasting damage to organs: Study
- Salivary duct treatment eases dry mouth in Sjögren’s disease: Study
- 4 genes linked to inflammatory cell death very active in Sjögren’s
- AI can see what doctors miss to accurately diagnose Sjögren’s
- Worse fatigue tied to more pain in people with Sjögren’s, study finds
- Dazodalibep therapy now in Phase 3 testing for Sjögren’s disease
- Sjögren’s treatment ianalumab shows rapid disease relief in trials